Anshul is the Co-Founder & CEO of Neuromersiv, a pioneering Sydney-based Medtech startup transforming neuro-rehabilitation using Virtual Reality. Under his leadership, Neuromersiv has participated in Australia’s top accelerators, including Muru-D, Cicada Medlab, and Medtech Actuator, and secured nearly $2 million in seed and grant funding, including from the prestigious BioMedTech Horizons Program (BMTH) by MTPConnect.Anshul successfully led the regulatory approvals (TGA & UKCA) and commercialization of 'Ulysses', Neuromersiv's innovative VR-based upper-limb rehabilitation system (Class 1 medical device). He also established high-impact strategic partnerships with leading stroke hospitals, neuro-rehabilitation centers, and academic institutions, all dedicated to advancing innovation and best practices in rehabilitation therapy.With a strong track record in Medtech and digital health commercialisation, Anshul excels in clinical development, regulatory compliance, quality management (ISO 13485, ICE 62304), and reimbursement strategies. As a product manager, he has overseen every aspect of product lifecycle management, from R&D to customer feedback integration, ensuring a user-centered approach to product development. Additionally, Anshul is deeply committed to customer engagement, conducting in-depth product demos, onboarding sessions, and personalised support, ensuring successful implementation and long-term satisfaction.His expertise spans the intersection of XR, healthcare, and enterprise applications, with extensive experience in the strategic development and deployment of Virtual and Augmented Reality technologies. Beyond Neuromersiv, he has consulted for blue-chip clients, including KPMG Australia, advising on immersive technology strategies that drive innovation across industries such as healthcare and entertainment.
Listed skills include Online Marketing, Social Media Marketing, E Commerce, Seo, and 17 others.